Blog

Evidence-based longevity analysis.

Deep dives on aging reversal technologies. What the research actually shows.

SGLT2 Inhibitors: The Longevity Drug With the Best Human Data

A diabetes drug that flushes 70 grams of glucose per day, extends mouse lifespan by 14%, and has more human mortality data than rapamycin and metformin combined.

Read →
The Longevity Spending Curve

The first $50/month buys 80% of the evidence base. The next $100,000 buys the feeling of doing something. Here's the math on what actually works.

Read →
Rapamycin for Longevity: What 47 Studies Actually Show

The most consistent animal longevity data of any compound. But the gap between mouse models and human evidence is wider than most longevity clinics will tell you.

Read →
GLP-1 Drugs and Aging: The Connection Your Doctor Isn't Making

Originally for diabetes. Then weight loss. Now the anti-inflammatory and neuroprotective data is piling up. This might be the biggest longevity story of 2025-2026.

Read →
Your Longevity Blood Panel Is Using the Wrong Ranges

Standard reference ranges are population averages, not longevity benchmarks. The difference between "normal" and "optimal" is where the actionable data lives.

Read →